C9orf10/Ossa regulates the bone metastasis of established lung adenocarcinoma cell subline H322L-BO4 in a mouse model
View abstract on PubMed
Summary
This summary is machine-generated.Researchers developed a new mouse model for lung cancer bone metastasis. Targeting chromosome 9 open reading frame 10/oxidative stress-associated Src activator (C9orf10/Ossa) reduced metastasis and improved survival.
Area Of Science
- Oncology
- Cancer Metastasis Research
- Molecular Biology
Background
- Lung cancer commonly metastasizes to bone, necessitating models to study and treat this progression.
- Existing models lack specificity for bone metastasis, hindering therapeutic target identification.
Purpose Of The Study
- To establish a novel in vivo model for lung cancer bone metastasis.
- To identify molecular targets for preventing and treating lung cancer bone metastasis.
Main Methods
- Developed a lung adenocarcinoma cell subline (H322L-BO4) with specific bone metastasis potential through serial passaging in mice.
- Injected cells intracardially into nude mice to assess metastatic behavior and survival.
- Investigated the role of chromosome 9 open reading frame 10/oxidative stress-associated Src activator (C9orf10/Ossa) and Src family tyrosine kinase signaling.
Main Results
- H322L-BO4 cells demonstrated specific metastasis to leg bones and adrenal glands in mice.
- Increased phosphorylation of C9orf10/Ossa in H322L-BO4 cells correlated with enhanced anchorage independence.
- Reducing C9orf10/Ossa expression via shRNA significantly decreased bone metastasis and prolonged mouse survival.
Conclusions
- The H322L-BO4 cell line serves as a valuable model for evaluating therapeutic strategies against lung cancer bone metastasis.
- C9orf10/Ossa is implicated in lung cancer bone metastasis and represents a potential therapeutic target.

